Search

Zentalis Pharmaceuticals Inc

Lezárt

5.1 12.33

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

4.44

Maximum

4.74

Fő mutatók

By Trading Economics

Bevétel

-136K

-35M

Egy részvényre jutó nyereség

-0.503

Munkavállalók

106

EBITDA

2.2M

-35M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+45.95% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. aug. 4.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

34M

329M

Előző nyitás

-7.23

Előző zárás

5.1

Zentalis Pharmaceuticals Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. júl. 17. 23:56 UTC

Correlated Moves

Applied Materials Inc shares are lower in after-market hours, continuing a decline since Friday amid rising oil prices and geopolitical tensions impacting the semiconductor sector.

2026. júl. 17. 23:56 UTC

Automatic Data Processing shares are lower in after-market hours, declining from a session high amid rising oil prices and geopolitical tensions impacting broader market dynamics.

2026. júl. 17. 23:56 UTC

ETF Constituents
Macro News

Consumer Staples Select Sector SPDR Fund declines in after-market trading amid broader market weakness, driven by technology stock declines and rising geopolitical tensions.

2026. júl. 17. 23:56 UTC

Comcast Corp. shares are higher in after-market hours, reflecting stability near the upper end of their one-month range amid geopolitical tensions and rising oil prices.

2026. júl. 17. 23:56 UTC

The S&P 500 Index is roughly flat in after-market trading. Geopolitical tensions in the Middle East are influencing market dynamics and raising inflation concerns.

2026. júl. 17. 23:56 UTC

News
Social Media

Micron Technology shares are lower in after-market trading amid a decline in India's smartphone shipments and ongoing memory cost pressures affecting margins.

2026. júl. 17. 23:56 UTC

No specific news for Adobe Inc. Shares are trading roughly flat in after-market hours, reflecting a slight increase since Friday's close.

2026. júl. 17. 23:51 UTC

European equity indices mixed as geopolitical tensions and rising oil prices heighten inflation fears, while Eurozone inflation eases to a four-month low.

2026. júl. 17. 23:51 UTC

Asia equity markets decline sharply amid geopolitical tensions and global tech sell-off, raising concerns over inflation and economic stability.

2026. júl. 17. 23:51 UTC

U.S. equity indices remain flat amid mixed market sentiment, geopolitical tensions, and tech stock declines, while Asian markets face significant losses.

2026. júl. 17. 23:51 UTC

Global equity markets decline amid mixed U.S. economic data and escalating geopolitical tensions, with Asia seeing significant losses.

2026. júl. 17. 23:51 UTC

ECB Expected to Raise Interest Rates Amid Rising Inflation Pressures and Geopolitical Tensions on July 23, 2026.

2026. júl. 17. 23:51 UTC

ECB's Deposit Facility Rate Expected to Rise Amid Geopolitical Tensions and Inflation Concerns, Forecasted at 0.0225% for July 23, 2026

2026. júl. 17. 23:46 UTC

Cisco Systems Inc. shares are lower in after-market hours amid broader declines in the technology sector and increased market volatility linked to geopolitical tensions.

2026. júl. 17. 23:46 UTC

Check Point Software shares are higher in after-market trading, continuing a trend of three consecutive gains. No specific news was identified to explain the movement.

2026. júl. 17. 23:46 UTC

Correlated Moves

Lam Research shares traded lower in after-market hours, reflecting broader technology sector declines amid rising geopolitical tensions and concerns over inflation and interest rates.

2026. júl. 17. 23:46 UTC

ETF Constituents

iShares MSCI Brazil ETF rises in after-market hours, led by Banco do Brasil and Petrobras A, despite broader declines in global equity indices.

2026. júl. 17. 23:46 UTC

Macro News
ETF Constituents

Crude oil prices surged amid heightened geopolitical risks, boosting the Energy Select Sector SPDR Fund's performance during after-market hours.

2026. júl. 17. 23:41 UTC

China's Loan Prime Rate 5Y set to remain steady at 3.50% amid stable market sentiment ahead of July 20, 2026 release.

2026. júl. 17. 23:41 UTC

China's Loan Prime Rate Expected to Remain Unchanged at 0.03% Amid Global Interest Rate Hikes Ahead of July 20 Announcement

2026. júl. 17. 23:41 UTC

Macro News
Correlated Moves

After market hours, iShares MSCI Germany ETF trends lower amid ongoing weakness in technology stocks and rising geopolitical tensions between the U.S. and Iran.

2026. júl. 17. 23:41 UTC

Macro News
Correlated Moves

iShares MSCI South Korea ETF declines in after-hours trading amid broader market weakness and geopolitical tensions, reflecting a cumulative return of -0.39% since Friday's close.

2026. júl. 17. 23:41 UTC

Macro News

Bitcoin is trading higher as geopolitical tensions drive crude oil prices up. The cryptocurrency remains above its 20-day moving average amid rising inflation concerns.

2026. júl. 17. 23:36 UTC

News

GameStop increased its stake in eBay to nearly 10%, acquiring 3.5 million shares for about $381 million. eBay shares are gaining in after-market trading.

2026. júl. 17. 23:36 UTC

Macro News
News
ETF Constituents

Vanguard Information Technology ETF rises slightly in after-market trading, supported by gains in Microsoft, Analog Devices, Adobe, Qualcomm, and Snowflake.

2026. júl. 17. 23:36 UTC

Correlated Moves

Texas Instruments shares declined in after-market trading amid broader technology sector weakness, following four consecutive lower daily closes.

2026. júl. 17. 23:36 UTC

Correlated Moves

Synopsys Inc shares are lower in after-market trading, reflecting broader tech sector selling pressure amid profit-taking and valuation concerns ahead of earnings reports.

2026. júl. 17. 23:36 UTC

Cadence Design Systems shares are higher in after-market hours, diverging from broader tech sector weakness amid profit-taking and valuation concerns ahead of earnings.

2026. júl. 17. 23:26 UTC

ETF Constituents

Vanguard Value ETF gains in after-market trading, supported by key holdings. Despite broader market pressures, the ETF shows modest increases.

2026. júl. 17. 23:26 UTC

Costco Wholesale Corp shares are lower in after-market hours, with no specific news identified to explain the decline since Friday's close.

Társak összehasonlítása

Árváltozás

Zentalis Pharmaceuticals Inc Előrejelzés

Célár

By TipRanks

45.95% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 6.67 USD  45.95%

Magas 10 USD

Alacsony 4 USD

7 Wall Street elemző 12 hónapos célárain alapulva a(z)Zentalis Pharmaceuticals Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

7 ratings

4

Vétel

3

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat